ライフサイエンスコーパス: overlap syndrome

1 t they have asthma, COPD, or asthma and COPD overlap syndrome.

2 This article reviews the asthma-COPD overlap syndrome.

3 bsequent development of autoimmune hepatitis overlap syndrome.

4 nel mutation causing a cardiac Na(+) channel overlap syndrome.

5 associated with the polymyositis-scleroderma overlap syndrome.

6 tients with systemic lupus erythematosus and overlap syndrome.

7 is, scleroderma, or polymyositis-scleroderma overlap syndrome.

8 ents suffering from polymyositis-scleroderma overlap syndrome.

9 or an undifferentiated autoimmune rheumatic/overlap syndrome.

10 , resource usage, and costs in patients with overlap syndrome.

11 give clues as to the presence of associated overlap syndrome.

12 stinal and non-gastrointestinal symptoms and overlap syndromes.

13 useful in the diagnosis of antibody-negative overlap syndromes.

14 uropathy, progeria, bone/skin disorders, and overlap syndromes.

15 2% MELAS/chronic PEO (CPEO) and 5% MIDD/CPEO overlap syndromes.

16 and autoimmunity, cryptogenic hepatitis, and overlap syndromes.

17 ers such as myositis, systemic sclerosis and overlap syndromes.

18 rstood as a spectrum of multiple potentially overlapping syndromes.

19 lso in Homo sapiens polymyositis-scleroderma overlap syndrome 100 kDa autoantigen and Werner syndrome

20 ence") involved weaker clustering and mostly overlapped syndromes 2 and 3.

21 Some studies suggest that asthma-COPD overlap syndrome (ACOS) is associated with worse outcome

22 Asthma-COPD overlap syndrome (ACOS) was defined as the coexistence o

23 asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS), but as yet, it lacks a precise

24 designated as mixed asthma-COPD phenotype or overlap syndrome (ACOS), remains a controversial issue.

25 A differentiation of these somewhat overlapping syndromes and the disparate treatment regime

26 f OSA with chronic obstructive lung disease (overlap syndrome) and morbid obesity (obesity hypoventil

27 pathogenic, that it can cause an LHON/MELAS overlap syndrome, and that it may be a more frequent cau

28 eroid resistance is a feature of asthma-COPD overlap syndrome, and understanding the various molecula

29 f Leigh syndrome, including association with overlapping syndromes, and the correlation of pathogenic

30 Myositis-overlap syndromes are characterized by a heterogeneous g

31 Variant or overlapping syndromes are worthy of consideration when u

32 Some patients with overlap syndromes can be conveniently treated with tripl

33 In the SCN5A overlap syndrome, excess mortality was observed between

34 This new muscle connective tissue overlap syndrome expands on the emerging importance of t

35 of anti-tRNA synthetase antibody-associated overlap syndromes has expanded; antibodies to the autoan

36 hronic obstructive pulmonary disease, termed overlap syndrome, has a poor prognosis.

37 of PIK3CA in ten additional individuals with overlapping syndromes identified either the p.His1047Leu

38 ed adjudicated claims data for patients with overlap syndrome in the United States were linked to obj

39 Overlap syndromes include combinations of autoimmune hep

40 myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leuka

41 odysplastic syndrome (MDS), or mixed MDS/MPN overlap syndrome (including chronic myelomonocytic leuke

42 collagen XII (COL12A1) as underlying a novel overlap syndrome involving muscle and connective tissue.

43 ng with immune-related myocarditis, and this overlap syndrome is associated with substantially increa

44 Ocular involvement in SJS, TEN, and Overlap syndrome is common and the ocular manifestations

45 We conclude that HSP/overlap syndrome may be the initial manifestation of IgA

46 evidence that patients with the asthma-COPD overlap syndrome might benefit from inhaled corticostero

47 d occur either in isolation or as part of an overlap syndrome (N=44), and were designated core manife

48 ther connective tissue disease (myositis-CTD overlap syndrome) (n=64), or juvenile DM (n=101), in com

49 This is especially evident with the overlap syndrome now documented for several sodium chann

50 nile DM and not in patients with juvenile DM-overlap syndrome or control subjects.

51 ome III FD subtypes were uniquely related to overlap syndromes or symptoms.

52 h autoimmune hepatitis and another disorder (overlap syndromes) or findings that are inconsistent wit

53 C), Primary Sclerosing Cholangitis (PSC) and Overlap Syndrome (OS)] referred to Middle East Liver Dis

54 d patients with (n = 9) and without (n = 33) overlap syndrome (p = 0.005).

55 Conversely, in overlap syndrome patients, both transaminases and alkali

56 m some patients with polymyositis-scleoderma overlap syndrome (PM-SCL) recognize two antigenically un

57 eting diagnostic criteria for SLE or a lupus overlap syndrome), precipitated new phosphoproteins from

58 lized as a spectrum of multiple, potentially overlapping syndromes rather than a unitary nosologic en

59 70%) of and 28 (58.4%) patients with AIH and overlap syndrome respectively and 21 patients 11 (6.9%)

60 The ciliopathies include several partially overlapping syndromes such as Joubert syndrome, Bardet-B

61 Overlap syndromes/symptoms did not vary by FD subtype.

62 e (IBD) intersect to form a scantily defined overlap syndrome, termed pre-IBD.

63 rugs are finally being tested in these rare "overlap" syndromes that have both dysplastic and prolife

64 ndrome-hereditary hemorrhagic telangiectasia overlap syndrome) that can result in epistaxis, gastroin

65 ese symptoms suggests the existence of three overlapping syndromes: the winter-over syndrome, the pol

66 Conclusions: PAP usage by patients with overlap syndrome was associated with reduced all-cause h

67 Histology suggestive of overlap syndrome was seen in 3 of 12 native livers with

68 ren between 2001 and 2011 with SJS, TEN, and Overlap syndrome were reviewed.

69 patients 11 (6.9%) of AIH and 10 (20.8%) of overlap syndrome) were non-responders.

70 e is the treatment of choice for scleroderma overlap syndromes, whereas mycophenolate and azathioprin

71 H, 37 (14.0%) PBC, 20 (7.5%) PSC, 48 (18.1%) overlap syndrome) with a median follow-up time of 5 year